Guangzhou Wondfo Biotech Co Ltd
SZSE:300482

Watchlist Manager
Guangzhou Wondfo Biotech Co Ltd Logo
Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
Watchlist
Price: 24.29 CNY -6.22% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Guangzhou Wondfo Biotech Co Ltd?
Write Note

Gross Margin
Guangzhou Wondfo Biotech Co Ltd

62.6%
Current
57%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
62.6%
=
Gross Profit
1.8B
/
Revenue
2.9B

Gross Margin Across Competitors

Country CN
Market Cap 11.5B CNY
Gross Margin
63%
Country US
Market Cap 204.9B USD
Gross Margin
56%
Country US
Market Cap 195.2B USD
Gross Margin
67%
Country US
Market Cap 146.7B USD
Gross Margin
64%
Country US
Market Cap 132.6B USD
Gross Margin
69%
Country IE
Market Cap 110.6B USD
Gross Margin
66%
Country US
Market Cap 64.7B USD
Gross Margin
45%
Country DE
Market Cap 55.6B EUR
Gross Margin
38%
Country CN
Market Cap 319.2B CNY
Gross Margin
65%
Country US
Market Cap 41.6B USD
Gross Margin
79%
Country US
Market Cap 37.7B USD
Gross Margin
41%
No Stocks Found

Guangzhou Wondfo Biotech Co Ltd
Glance View

Market Cap
11.5B CNY
Industry
Health Care

Guangzhou Wondfo Biotech Co., Ltd. engages in the manufacture and sale of biochemical reagents, medical products and diagnostic test kits. The company is headquartered in Guangzhou, Guangdong and currently employs 3,411 full-time employees. The company went IPO on 2015-06-30. According to the testing result, the Company' products can be divided into qualitative testing products and quantitative testing products. According to the usage, the Company' products include pregnancy testing series, infectious diseases testing series, drugs (drug abuse) testing series and chronic disease testing series. The firm's products are used in POCT, clinical test, field test and personal health management, among others.

Intrinsic Value
42.67 CNY
Undervaluation 43%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
62.6%
=
Gross Profit
1.8B
/
Revenue
2.9B
What is the Gross Margin of Guangzhou Wondfo Biotech Co Ltd?

Based on Guangzhou Wondfo Biotech Co Ltd's most recent financial statements, the company has Gross Margin of 62.6%.